CASP4 can be a diagnostic biomarker and correlated with immune infiltrates in gliomas
BackgroundGliomas are the most common and invasive malignant tumors that originate in the central nervous system. Currently, the primary treatment modality for gliomas is maximum surgical resection, supplemented by radiotherapy and chemotherapy. However, the long-term survival rate has not signififi...
Main Authors: | Guopeng Tian, Qiao Li, Liang Niu, Yusong Luo, Hongyu Wang, Wei Kang, Xiang Fang, Shengwei Bai, Guoqiang Yuan, Yawen Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1025065/full |
Similar Items
-
CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment
by: Kai Guo, et al.
Published: (2022-09-01) -
Testis cell pyroptosis mediated by CASP1 and CASP4: possible sertoli cell-only syndrome pathogenesis
by: Wantao Liu, et al.
Published: (2023-06-01) -
Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities
by: Yusong Luo, et al.
Published: (2022-10-01) -
Study the Effect of Eugenol on CASP8 and CASP9 Gene\'s Expression in Colon Cancer Cell Lines HT-29
by: Milad Banitalebi Dehkordi, et al.
Published: (2019-12-01) -
A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy
by: Zheng Zhou, et al.
Published: (2022-04-01)